nl
Participating in early clinical research
Sometimes standard treatments for cancer are not (or no longer) possible or have insufficient effect. In that case, participation in an early clinical trial may be an option.
To participate in a study of the NKI Center for Early Clinical Research, you must meet certain conditions. Registration is always done through your attending physician.
On this page, we explain step by step how the registration process, what the screening entails and what you can expect when treatment starts.
The most important conditions for participating in a study are:
1. The type of cancer or the characteristics of the tumor must match the study.
2. Your condition must be good enough.
3. To determine the effect of the treatment, the tumor must be scanned and measured by a radiologist.
4. You must have adequate heart, kidney, and liver function. Red and white blood cells and platelets must be sufficient.
5. A biopsy of the tumor or metastasis must be a possibility.
2. Your condition must be good enough.
3. To determine the effect of the treatment, the tumor must be scanned and measured by a radiologist.
4. You must have adequate heart, kidney, and liver function. Red and white blood cells and platelets must be sufficient.
5. A biopsy of the tumor or metastasis must be a possibility.